TAIKO PHARMACEUTICAL CO.,LTD.
大幸薬品株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4574
FY2025 · 2025-12-31
| Gross margin | 54.4% |
| Operating margin | 7.2% |
| Net margin | 14.4% |
| Return on equity | 11.3% |
| Return on assets | 7.5% |
| Revenue growth (YoY) | 1.7% |
| EPS (basic) | ¥18.38 |
| EPS growth (YoY) | 2.7% |
| Current ratio | 3.36x |
| Equity ratio | 66.8% |
| Book value / share | ¥169.51 |
| Free cash flow | 523 M |